Interventional prospective randomized open blinded end-point (PROBE) single-center clinical trial on the evaluation of the efficacy, safety, feasibility, reliability, and cost-effectiveness of in-ambulance telemedicine for patients with suspicion of acute stroke.
The purpose of PreSSUB II is to evaluate the efficacy, safety, feasibility, reliability and cost-effectiveness of in-ambulance telemedicine during Paramedic Intervention Team transportation of patients with suspicion of acute stroke.
The implementation of expert stroke support in the pre-hospital arena using in-ambulance telemedicine is an innovative approach that opens up new perspectives and allows continuous guidance by a stroke specialist throughout the acute stroke care continuum.
- Telemedicine Other
Intervention Desc: In-ambulance telemedicine ARM 1: Kind: Experimental Label: Telemedicine Description: In-ambulance teleconsultation by a stroke expert aiming to support the Paramedic Intervention Team by focusing on patient identification, obtaining homeostasis (optimal control of blood pressure, blood oxygenation, temperature, heart rate and rhythm, glycemia), assessment of the patient's neurological status, stroke diagnosis, hospital notification, and patient selection for specific stroke treatment.
- Allocation: Randomized
- Masking: Single Blind (Outcomes Assessor)
- Purpose: Supportive Care
- Endpoint: Efficacy Study
- Intervention: Parallel Assignment
|Type||Measure||Time Frame||Safety Issue|
|Primary||Call-to-brain imaging time||within 2 hours||No|
|Secondary||Medical events during in-ambulance telemedicine||within 2 hours||No|
|Secondary||Recanalisation therapy||upto 8 hours||No|
|Secondary||Clinical outcome||upto 12 months||No|